000 | 01962 a2200517 4500 | ||
---|---|---|---|
005 | 20250514163710.0 | ||
264 | 0 | _c20040628 | |
008 | 200406s 0 0 eng d | ||
022 | _a0340-7004 | ||
024 | 7 |
_a10.1007/s00262-003-0466-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTakahashi, Akihiro | |
245 | 0 | 0 |
_aVascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. _h[electronic resource] |
260 |
_bCancer immunology, immunotherapy : CII _cJun 2004 |
||
300 |
_a543-50 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _ximmunology |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xmetabolism |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
650 | 0 | 4 |
_aDinoprostone _xpharmacology |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
650 | 0 | 4 |
_aInterleukin-12 _xmetabolism |
650 | 0 | 4 |
_aInterleukin-6 _xpharmacology |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxytocics _xpharmacology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aStomach Neoplasms _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xmetabolism |
700 | 1 | _aKono, Koji | |
700 | 1 | _aIchihara, Fumiko | |
700 | 1 | _aSugai, Hidemitsu | |
700 | 1 | _aFujii, Hideki | |
700 | 1 | _aMatsumoto, Yoshiro | |
773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 53 _gno. 6 _gp. 543-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-003-0466-8 _zAvailable from publisher's website |
999 |
_c14399300 _d14399300 |